Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 72: 2271-2277, 1992;
8750-7587/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Read, R. C.
Right arrow Articles by et, al.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Read, R. C.
Right arrow Articles by et, al.

Journal of Applied Physiology, Vol 72, Issue 6 2271-2277, Copyright © 1992 by American Physiological Society

ARTICLES

Effect of Pseudomonas aeruginosa rhamnolipids on mucociliary transport and ciliary beating

R. C. Read, P. Roberts, N. Munro, A. Rutman, A. Hastie, T. Shryock, R. Hall, W. McDonald-Gibson, V. Lund, G. Taylor and al. et
Department of Thoracic Medicine, National Heart and Lung Institute, London, United Kingdom.

Pseudomonas aeruginosa rhamnolipid causes ciliostasis and cell membrane damage to rabbit tissue, is a secretagogue in cats, and inhibits epithelial ion transport in sheep tissue. It could therefore perturb mucociliary clearance. We have investigated the effect of rhamnolipid on mucociliary transport in the anesthetized guinea pig and guinea pig and human respiratory epithelium in vitro. Application of rhamnolipid to the guinea pig tracheal mucosa reduced tracheal mucus velocity (TMV) in vivo in a dose-dependent manner: a 10-microgram bolus caused cessation of TMV without recovery; a 5-micrograms bolus reduced TMV over a period of 2 h by 22.6% (P = 0.037); a 2.5-microgram bolus caused no overall changes in TMV. The ultrastructure of guinea pig tracheal epithelium exposed to 10 micrograms of rhamnolipid in vivo was normal. Application of 1,000 micrograms/ml rhamnolipid had no effect on the ciliary beat frequency (CBF) of guinea pig tracheal rings in vitro after 30 min, but 250 micrograms/ml stopped ciliary beating after 3 h. Treatment with 100 micrograms/ml rhamnolipid caused immediate slowing of the CBF (P less than 0.01) of human nasal brushings (n = 7), which was maintained for 4 h. Mono- and dirhamnolipid had equivalent effects. The CBF of human nasal turbinate organ culture was also slowed by 100 micrograms/ml rhamnolipid, but only after 4 h (CBF test, 9.87 +/- 0.41 Hz; control, 11.48 +/- 0.27 Hz; P less than 0.05, n = 6), and there was subsequent recovery by 14 h.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
P. Meers, M. Neville, V. Malinin, A. W. Scotto, G. Sardaryan, R. Kurumunda, C. Mackinson, G. James, S. Fisher, and W. R. Perkins
Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections
J. Antimicrob. Chemother., April 1, 2008; 61(4): 859 - 868.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
H. Abusriwil and R. A. Stockley
The Interaction of Host and Pathogen Factors in Chronic Obstructive Pulmonary Disease Exacerbations and Their Role in Tissue Damage
Proceedings of the ATS, December 1, 2007; 4(8): 611 - 617.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
S. Wilhelm, A. Gdynia, P. Tielen, F. Rosenau, and K.-E. Jaeger
The Autotransporter Esterase EstA of Pseudomonas aeruginosa Is Required for Rhamnolipid Production, Cell Motility, and Biofilm Formation
J. Bacteriol., September 15, 2007; 189(18): 6695 - 6703.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. W. Calfee, J. G. Shelton, J. A. McCubrey, and E. C. Pesci
Solubility and Bioactivity of the Pseudomonas Quinolone Signal Are Increased by a Pseudomonas aeruginosa-Produced Surfactant
Infect. Immun., February 1, 2005; 73(2): 878 - 882.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. Zhu, R. Bandara, T. C. R. Conibear, S. J. Thuruthyil, S. A. Rice, S. Kjelleberg, M. Givskov, and M. D. P. Willcox
Pseudomonas aeruginosa with LasI Quorum-Sensing Deficiency during Corneal Infection
Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1897 - 1903.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
E. Deziel, F. Lepine, S. Milot, and R. Villemur
rhlA is required for the production of a novel biosurfactant promoting swarming motility in Pseudomonas aeruginosa: 3-(3-hydroxyalkanoyloxy)alkanoic acids (HAAs), the precursors of rhamnolipids
Microbiology, August 1, 2003; 149(8): 2005 - 2013.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
R. B. Dowling, R. Newton, A. Robichaud, P. J. Cole, P. J. Barnes, and R. Wilson
Effect of Inhibition of Nitric Oxide Synthase on Pseudomonas aeruginosa Infection of Respiratory Mucosa In Vitro
Am. J. Respir. Cell Mol. Biol., December 1, 1998; 19(6): 950 - 958.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online